1. Home
  2. HSBC vs GKOS Comparison

HSBC vs GKOS Comparison

Compare HSBC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSBC
  • GKOS
  • Stock Information
  • Founded
  • HSBC 1865
  • GKOS 1998
  • Country
  • HSBC United Kingdom
  • GKOS United States
  • Employees
  • HSBC N/A
  • GKOS N/A
  • Industry
  • HSBC Savings Institutions
  • GKOS Medical/Dental Instruments
  • Sector
  • HSBC Finance
  • GKOS Health Care
  • Exchange
  • HSBC Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • HSBC 180.3B
  • GKOS 5.1B
  • IPO Year
  • HSBC N/A
  • GKOS 2015
  • Fundamental
  • Price
  • HSBC $52.50
  • GKOS $90.26
  • Analyst Decision
  • HSBC Buy
  • GKOS Strong Buy
  • Analyst Count
  • HSBC 1
  • GKOS 13
  • Target Price
  • HSBC N/A
  • GKOS $155.00
  • AVG Volume (30 Days)
  • HSBC 3.0M
  • GKOS 1.0M
  • Earning Date
  • HSBC 04-29-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • HSBC 8.25%
  • GKOS N/A
  • EPS Growth
  • HSBC 8.77
  • GKOS N/A
  • EPS
  • HSBC 1.24
  • GKOS N/A
  • Revenue
  • HSBC $61,253,000,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • HSBC $8.82
  • GKOS $27.84
  • Revenue Next Year
  • HSBC $1.91
  • GKOS $27.99
  • P/E Ratio
  • HSBC $8.04
  • GKOS N/A
  • Revenue Growth
  • HSBC 8.70
  • GKOS 21.85
  • 52 Week Low
  • HSBC $39.42
  • GKOS $77.91
  • 52 Week High
  • HSBC $61.88
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • HSBC 46.48
  • GKOS 41.57
  • Support Level
  • HSBC $51.76
  • GKOS $86.16
  • Resistance Level
  • HSBC $50.04
  • GKOS $94.55
  • Average True Range (ATR)
  • HSBC 1.49
  • GKOS 6.54
  • MACD
  • HSBC -0.03
  • GKOS 1.11
  • Stochastic Oscillator
  • HSBC 55.30
  • GKOS 54.51

About HSBC HSBC Holdings plc.

Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in around 60 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: